Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy
Authors
Keywords
-
Journal
Journal of Immunotoxicology
Volume 11, Issue 4, Pages 319-327
Publisher
Informa UK Limited
Online
2013-12-19
DOI
10.3109/1547691x.2013.864736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
- (2012) Andrew P. Hinck FEBS LETTERS
- Immunology beats cancer: a blueprint for successful translation
- (2012) Drew M Pardoll NATURE IMMUNOLOGY
- Tumor associated regulatory dendritic cells
- (2012) Yang Ma et al. SEMINARS IN CANCER BIOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Comprehensive analysis of TGF-β and BMP receptor interactomes
- (2011) Mohammad Poorgholi Belverdi et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation
- (2011) Yumiko Yoshioka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8
- (2011) D T N Shola et al. ONCOGENE
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
- (2010) Ye Zheng et al. NATURE
- Adoptive immunotherapy of cancer using CD4+ T cells
- (2009) Pawel Muranski et al. CURRENT OPINION IN IMMUNOLOGY
- Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
- (2009) H. Senta et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Synergistic effect of TGF-β superfamily members on the induction of Foxp3+ Treg
- (2009) Ling Lu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Promising novel immunotherapies and combinations for prostate cancer
- (2009) Philip M Arlen et al. Future Oncology
- TCR Repertoire and Foxp3 Expression Define Functionally Distinct Subsets of CD4+ Regulatory T Cells
- (2009) M. Kuczma et al. JOURNAL OF IMMUNOLOGY
- Activin A Promotes the TGF- -Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells
- (2009) S. Huber et al. JOURNAL OF IMMUNOLOGY
- Foxp3-Deficient Regulatory T Cells Do Not Revert into Conventional Effector CD4+ T Cells but Constitute a Unique Cell Subset
- (2009) M. Kuczma et al. JOURNAL OF IMMUNOLOGY
- Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor
- (2009) Yann M Kerdiles et al. NATURE IMMUNOLOGY
- Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages
- (2009) Andrew Gray et al. VACCINE
- Signaling cross-talk between TGF-β/BMP and other pathways
- (2008) Xing Guo et al. CELL RESEARCH
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started